171 related articles for article (PubMed ID: 8723647)
1. Mutation of R555 in CFTR-delta F508 enhances function and partially corrects defective processing.
Teem JL; Carson MR; Welsh MJ
Recept Channels; 1996; 4(1):63-72. PubMed ID: 8723647
[TBL] [Abstract][Full Text] [Related]
2. Analysis of the localization of STE6/CFTR chimeras in a Saccharomyces cerevisiae model for the cystic fibrosis defect CFTR delta F508.
Paddon C; Loayza D; Vangelista L; Solari R; Michaelis S
Mol Microbiol; 1996 Mar; 19(5):1007-17. PubMed ID: 8830258
[TBL] [Abstract][Full Text] [Related]
3. Identification of revertants for the cystic fibrosis delta F508 mutation using STE6-CFTR chimeras in yeast.
Teem JL; Berger HA; Ostedgaard LS; Rich DP; Tsui LC; Welsh MJ
Cell; 1993 Apr; 73(2):335-46. PubMed ID: 7682896
[TBL] [Abstract][Full Text] [Related]
4. A novel natural product compound enhances cAMP-regulated chloride conductance of cells expressing CFTR[delta]F508.
deCarvalho AC; Ndi CP; Tsopmo A; Tane P; Ayafor J; Connolly JD; Teem JL
Mol Med; 2002 Feb; 8(2):75-87. PubMed ID: 12080183
[TBL] [Abstract][Full Text] [Related]
5. Nanomolar affinity small molecule correctors of defective Delta F508-CFTR chloride channel gating.
Yang H; Shelat AA; Guy RK; Gopinath VS; Ma T; Du K; Lukacs GL; Taddei A; Folli C; Pedemonte N; Galietta LJ; Verkman AS
J Biol Chem; 2003 Sep; 278(37):35079-85. PubMed ID: 12832418
[TBL] [Abstract][Full Text] [Related]
6. Altered chloride ion channel kinetics associated with the delta F508 cystic fibrosis mutation.
Dalemans W; Barbry P; Champigny G; Jallat S; Dott K; Dreyer D; Crystal RG; Pavirani A; Lecocq JP; Lazdunski M
Nature; 1991 Dec 19-26; 354(6354):526-8. PubMed ID: 1722027
[TBL] [Abstract][Full Text] [Related]
7. Chemical chaperones correct the mutant phenotype of the delta F508 cystic fibrosis transmembrane conductance regulator protein.
Brown CR; Hong-Brown LQ; Biwersi J; Verkman AS; Welch WJ
Cell Stress Chaperones; 1996 Jun; 1(2):117-25. PubMed ID: 9222597
[TBL] [Abstract][Full Text] [Related]
8. Processing of mutant cystic fibrosis transmembrane conductance regulator is temperature-sensitive.
Denning GM; Anderson MP; Amara JF; Marshall J; Smith AE; Welsh MJ
Nature; 1992 Aug; 358(6389):761-4. PubMed ID: 1380673
[TBL] [Abstract][Full Text] [Related]
9. Mutations in the nucleotide binding domain 1 signature motif region rescue processing and functional defects of cystic fibrosis transmembrane conductance regulator delta f508.
DeCarvalho AC; Gansheroff LJ; Teem JL
J Biol Chem; 2002 Sep; 277(39):35896-905. PubMed ID: 12110684
[TBL] [Abstract][Full Text] [Related]
10. Functional activation of the cystic fibrosis trafficking mutant delta F508-CFTR by overexpression.
Cheng SH; Fang SL; Zabner J; Marshall J; Piraino S; Schiavi SC; Jefferson DM; Welsh MJ; Smith AE
Am J Physiol; 1995 Apr; 268(4 Pt 1):L615-24. PubMed ID: 7733303
[TBL] [Abstract][Full Text] [Related]
11. Phenylglycine and sulfonamide correctors of defective delta F508 and G551D cystic fibrosis transmembrane conductance regulator chloride-channel gating.
Pedemonte N; Sonawane ND; Taddei A; Hu J; Zegarra-Moran O; Suen YF; Robins LI; Dicus CW; Willenbring D; Nantz MH; Kurth MJ; Galietta LJ; Verkman AS
Mol Pharmacol; 2005 May; 67(5):1797-807. PubMed ID: 15722457
[TBL] [Abstract][Full Text] [Related]
12. A delta F508 mutation in mouse cystic fibrosis transmembrane conductance regulator results in a temperature-sensitive processing defect in vivo.
French PJ; van Doorninck JH; Peters RH; Verbeek E; Ameen NA; Marino CR; de Jonge HR; Bijman J; Scholte BJ
J Clin Invest; 1996 Sep; 98(6):1304-12. PubMed ID: 8823295
[TBL] [Abstract][Full Text] [Related]
13. The cystic fibrosis mutation (delta F508) does not influence the chloride channel activity of CFTR.
Li C; Ramjeesingh M; Reyes E; Jensen T; Chang X; Rommens JM; Bear CE
Nat Genet; 1993 Apr; 3(4):311-6. PubMed ID: 7526932
[TBL] [Abstract][Full Text] [Related]
14. Defects in processing and trafficking of cystic fibrosis transmembrane conductance regulator.
Kunzelmann K; Nitschke R
Exp Nephrol; 2000; 8(6):332-42. PubMed ID: 11014930
[TBL] [Abstract][Full Text] [Related]
15. Genistein potentiates wild-type and delta F508-CFTR channel activity.
Hwang TC; Wang F; Yang IC; Reenstra WW
Am J Physiol; 1997 Sep; 273(3 Pt 1):C988-98. PubMed ID: 9316420
[TBL] [Abstract][Full Text] [Related]
16. A mouse model for the delta F508 allele of cystic fibrosis.
Zeiher BG; Eichwald E; Zabner J; Smith JJ; Puga AP; McCray PB; Capecchi MR; Welsh MJ; Thomas KR
J Clin Invest; 1995 Oct; 96(4):2051-64. PubMed ID: 7560099
[TBL] [Abstract][Full Text] [Related]
17. Dysfunction of CFTR bearing the delta F508 mutation.
Welsh MJ; Denning GM; Ostedgaard LS; Anderson MP
J Cell Sci Suppl; 1993; 17():235-9. PubMed ID: 7511616
[TBL] [Abstract][Full Text] [Related]
18. 8-cyclopentyl-1,3-dipropylxanthine and other xanthines differentially bind to the wild-type and delta F508 first nucleotide binding fold (NBF-1) domains of the cystic fibrosis transmembrane conductance regulator.
Cohen BE; Lee G; Jacobson KA; Kim YC; Huang Z; Sorscher EJ; Pollard HB
Biochemistry; 1997 May; 36(21):6455-61. PubMed ID: 9174362
[TBL] [Abstract][Full Text] [Related]
19. Normal function of the cystic fibrosis conductance regulator protein can be associated with homozygous (Delta)F508 mutation.
Sermet-Gaudelus I; Vallée B; Urbin I; Torossi T; Marianovski R; Fajac A; Feuillet MN; Bresson JL; Lenoir G; Bernaudin JF; Edelman A
Pediatr Res; 2002 Nov; 52(5):628-35. PubMed ID: 12409506
[TBL] [Abstract][Full Text] [Related]
20. Protein kinase CK2, cystic fibrosis transmembrane conductance regulator, and the deltaF508 mutation: F508 deletion disrupts a kinase-binding site.
Treharne KJ; Crawford RM; Xu Z; Chen JH; Best OG; Schulte EA; Gruenert DC; Wilson SM; Sheppard DN; Kunzelmann K; Mehta A
J Biol Chem; 2007 Apr; 282(14):10804-13. PubMed ID: 17289674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]